Read more
5:17 PM · 19 July 2021

Moderna hit new ATH, company will join the S&P 500 index on Wednesday

-
-
Open account Download free app

Moderna (MRNA.US), an American company best known for its Covid-19 vaccine, was observed by many investors in recent days. Moderna shares have been gaining for several sessions in a row, climbing to new all-time high. Over the past week, the price has already increased by over 30%. From where did such strong price increases come from?

Before the session on July 21 (Wednesday), the company will join the S&P 500 index. The announcement from the index operator appeared last Thursday and led to increased interest in the company's shares during Friday's session during which the local volume high was also recorded. However, this does not change the fact that the upward movement continues, as the company may also benefit from the growing number of new coronavirus cases, and it should be remembered that in many underdeveloped countries the percentage of vaccinated people is still very low.

Moderna stocks (MRNA.US) broke above the $ 300 barrier today and price continues to climb higher. The gains clearly picked up after the price broke above the line drawn at the recent highs. If sellers manage to regain control, then the line should act as the first major support. Source: xStation5

30 January 2026, 5:25 PM

Gaming companies with huge discounts 🚨 Will Project Genie end the traditional era of gaming ❓

30 January 2026, 2:16 PM

Lockheed Martin earnings: The peak of global tensions and valuations

30 January 2026, 11:26 AM

Market wrap: European indices outperform US stocks ahead of the opening bell on Wall Street 📉

30 January 2026, 6:46 AM

Apple’s Record Quarter: iPhone, Services, and ‘Invisible’ AI. Is a Return to the Throne Imminent?

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits